Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic Functions
Authors
Sam Au Yeung
Helen Usansky
Eric Lawitz (ORCID: https://orcid.org/0000-0002-4234-224X)
Sherry Li
Daniel S. Stein
Zeid Kayali
Thomas C Marbury
Institutions
University of California, Riverside (US)
The University of Texas at San Antonio Health Science Center (US)
Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic Functions
Sam Au Yeung, Helen Usansky, Eric Lawitz, Sherry Li et al.
Journal
Clinical Pharmacokinetics
Topics
Drug-Induced Hepatotoxicity and Protection
article
Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic Functions
Sam Au Yeung, Helen Usansky, Eric Lawitz, Sherry Li, Daniel S. Stein, Zeid Kayali, Thomas C Marbury
article en
Abstract
No abstract available for this paper.
Publication Tag
Clinical PharmacokineticsVol. 65(3)
Institutions
University of California, Riverside (US), The University of Texas at San Antonio Health Science Center (US), Orlando Clinical Research Center (US), Insmed (United States) (US), Texas Liver Institute (US)